Cambio de mecanismo de acción viable en Psoriasis inducida por anti TNFi

Given Certain Factors, Patients With TNF Inhibitor-Induced Psoriasis Could Potentially Be Switched To A Different Drug Class, Researchers Say.

Rheumatology News (12/13, Craven) reports, "Patients with tumor necrosis factor [TNF] inhibitor–induced psoriasis could potentially be switched to a different drug class if they have moderate to severe skin eruption or mild skin eruption with an uncontrolled underlying disease such as inflammatory bowel disease, psoriasis, psoriatic arthritis, or rheumatoid arthritis," research indicated. The findings were published online as a review article in the Journal of Psoriasis and Psoriatic Arthritis.